Form 4 for MRNA Moderna
Accepted 2025-12-15 00:00:00 ET · period of report 2025-12-11 · accession 0001193125-25-318567 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-12-15 | 2025-12-11 | MRNA | AFEYAN NOUBAR | Dir | M - OptEx | $10.90 | +23.9K | 27.8K | +608% | +$260.0K |
| DI | 2025-12-15 | 2025-12-11 | MRNA | AFEYAN NOUBAR | Dir | S - Sale+OE | $29.49 | -23.9K | 3,924 | -86% | -$703.4K |
| DI | 2025-12-15 | 2025-12-11 | MRNA | AFEYAN NOUBAR | Dir | M - OptEx | $0.00 | -23.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-11 | M | A | 23,853 | $10.90 | 27,777 | I By Flagship Pioneering, Inc. | — | — | (F2) The securities are held directly by Flagship Pioneering. Flagship Pioneering is contractually obligated to transfer and/or remit the proceeds of any sale of shares to Flagship Fund IV, L.P. ("Flagship Fund IV"). The reporting person is the CEO and sole stockholder of Flagship Pioneering and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
| 2 | Common | Common Stock | 2025-12-11 | S | D | 23,853 | $29.49 | 3,924 | I By Flagship Pioneering, Inc. | — | — | (F2) The securities are held directly by Flagship Pioneering. Flagship Pioneering is contractually obligated to transfer and/or remit the proceeds of any sale of shares to Flagship Fund IV, L.P. ("Flagship Fund IV"). The reporting person is the CEO and sole stockholder of Flagship Pioneering and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-12-11 | M | D | 23,853 | $0.00 | 0 | I By Flagship Pioneering, Inc. | $10.90 · — to 2026-02-23 | 23,853 Common Stock | (F2) The securities are held directly by Flagship Pioneering. Flagship Pioneering is contractually obligated to transfer and/or remit the proceeds of any sale of shares to Flagship Fund IV, L.P. ("Flagship Fund IV"). The reporting person is the CEO and sole stockholder of Flagship Pioneering and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. (F5) The options were fully vested and exercisable. |